We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+16.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.2B
AUM Growth
+$1.49B
(+9%)
Cap. Flow
-$841M
Cap. Flow
% of AUM
-4.62%
Top 10 Holdings %
Top 10 Hldgs %
18.93%
Holding
2,614
New
37
Increased
460
Reduced
567
Closed
1,419
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$38.7M |
| 2 |
Dell
DELL
|
+$26.1M |
| 3 |
Automatic Data Processing
ADP
|
+$24.2M |
| 4 |
Cognizant
CTSH
|
+$23.3M |
| 5 |
Regions Financial
RF
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$87.4M |
| 2 |
Lam Research
LRCX
|
+$69.8M |
| 3 |
Visa
V
|
+$62.2M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$55.7M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$41.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.75% |
| 2 | Healthcare | 13.19% |
| 3 | Financials | 11.7% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Intellia Therapeutics
NTLA
$1.55B
| $481K | ﹤0.01% |
8,868
| – | – |
|
852
Sprott Physical Gold
PHYS
$14.8B
| $473K | ﹤0.01% |
31,380
| – | – |
|
853
Schneider National
SNDR
$5.98B
| $469K | ﹤0.01% |
22,678
-1,762
| -7% | -$39.4K |
|
854
Gen Digital
GEN
$16.3B
| $466K | ﹤0.01% |
22,443
-87,978
| -80% | -$1.78M |
|
|
MODN
855
DELISTED
MODEL N, INC.
MODN
| $466K | ﹤0.01% |
13,080
+5,792
| +79% | +$201K |
|
856
Mohawk Industries
MHK
$7.29B
| $465K | ﹤0.01% |
3,306
-416
| -11% | -$50.1K |
|
857
Rio Tinto
RIO
$158B
| $465K | ﹤0.01% |
6,212
-2,739
| -31% | -$180K |
|
858
Axsome Therapeutics
AXSM
$12.1B
| $462K | ﹤0.01% |
5,675
+562
| +11% | +$42K |
|
|
HOLX
859
DELISTED
Hologic
HOLX
| $461K | ﹤0.01% |
6,351
+319
| +5% | +$22.5K |
|
860
Invesco Biotechnology & Genome ETF
PBE
$286M
| $460K | ﹤0.01% |
6,579
| – | – |
|
|
DCPH
861
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $459K | ﹤0.01% |
8,054
+815
| +11% | +$48.3K |
|
862
Sonoco
SON
$5.62B
| $457K | ﹤0.01% |
7,731
-1,023
| -12% | -$57.5K |
|
863
Alexandria Real Estate Equities
ARE
$9.15B
| $452K | ﹤0.01% |
2,541
+1,976
| +350% | +$327K |
|
864
DXC Technology
DXC
$1.82B
| $451K | ﹤0.01% |
17,563
+856
| +5% | +$18.3K |
|
865
ePlus
PLUS
$2.38B
| $451K | ﹤0.01% |
10,268
-540
| -5% | -$21.6K |
|
|
AY
866
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $451K | ﹤0.01% |
11,895
-135
| -1% | -$4.46K |
|
|
ABMD
867
DELISTED
Abiomed Inc
ABMD
| $444K | ﹤0.01% |
1,371
-188
| -12% | -$52K |
|
868
Chesapeake Utilities
CPK
$3.2B
| $438K | ﹤0.01% |
4,049
-15,511
| -79% | -$1.55M |
|
869
Invesco Large Cap Growth ETF
PWB
$2.27B
| $435K | ﹤0.01% |
6,442
| – | – |
|
870
Southern Copper
SCCO
$145B
| $435K | ﹤0.01% |
7,220
-110
| -2% | -$5.66K |
|
871
Bank of Hawaii
BOH
$3.15B
| $434K | ﹤0.01% |
5,680
-1,956
| -26% | -$134K |
|
872
Nutrien
NTR
$33.9B
| $434K | ﹤0.01% |
9,044
-574
| -6% | -$25.4K |
|
873
State Street SPDR S&P Homebuilders ETF
XHB
$1.61B
| $433K | ﹤0.01% |
7,533
| – | – |
|
874
Packaging Corp of America
PKG
$22.2B
| $432K | ﹤0.01% |
3,142
+2,864
| +1,030% | +$361K |
|
875
Oshkosh
OSK
$8.82B
| $431K | ﹤0.01% |
5,018
-10,327
| -67% | -$822K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q4 2020 Portfolio in Review
As of Q4 2020, Glenmede Trust held 2,614 positions worth $18.2B, up 9% from $16.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Glenmede Trust withdrew a net $841M in Q4 2020, closing 1,419 positions and reducing 567 holdings. Its most notable exit was H&R Block, an estimated $18.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in CryoPort worth $974K.
- Glenmede Trust's largest Q4 2020 buy was CryoPort: 22,210 shares worth $974K.
- Glenmede Trust added most to iShares Core S&P Small-Cap ETF in Q4 2020, an estimated $38.7M increase.
- Glenmede Trust's biggest Q4 2020 reduction was Progressive, cutting an estimated $87.4M.
- Glenmede Trust fully exited H&R Block in Q4 2020, selling an estimated $18.3M.
- Glenmede Trust's ten largest holdings make up 19% of its $18.2B portfolio in Q4 2020.
- Glenmede Trust opened 37 new positions and closed 1,419 in Q4 2020.
- Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $18.2B.
Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.